Aurora Cannabis Inc. the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2022 on Tuesday, November 9, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time . The Company will report its financial results for the first quarter fiscal year 2022 after the close of markets that same day. ...

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2022 on Tuesday, November 9, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time . The Company will report its financial results for the first quarter fiscal year 2022 after the close of markets that same day.

Conference Call Details

DATE:


Tuesday, November 9, 2021

TIME:


5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time

WEBCAST:


Click here

Miguel Martin , Chief Executive Officer, and Glen Ibbott , Chief Financial Officer, will host the conference call and question and answer period. Investors may submit questions in advance or during the conference call through the weblink listed above. This weblink has also been posted to the Company's Investor Relations webpage at https://investor.auroramj.com/ under "News & Events".

About Aurora

Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company's brand portfolio includes Aurora, Aurora Drift , San Rafael '71 , Daily Special , MedReleaf, CanniMed, Pedanios, Whistler , Reliva and KG7 CBD . Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on Twitter and LinkedIn .

Aurora's common shares trade on the TSX and NASDAQ under the symbol "ACB" and is a constituent of the S&P/TSX Composite Index.

Forward Looking Statements

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include statements regarding timing of the release of the Company's financial statements for first quarter ended September 30, 2021 and scheduling of the conference call to discuss results.

These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions managements considers to be reasonable.  Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer  sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, including the current outbreak of COVID-19, and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated September 27, 2021 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC's website at www.sec.gov .  The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/aurora-cannabis-to-host-first-quarter-fiscal-year-2022-investor-conference-call-301409107.html

SOURCE Aurora Cannabis Inc.

News Provided by Canada Newswire via QuoteMedia

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Cronos Group Inc. with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofCronos Group Inc. ("Cronos" or "the Company") (NASDAQ:CRON) for violations of the securities laws

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9, 2021, disclosing that the Company would "be required to restate its previously issued unaudited interim financial statements for the three and six months ended June 30, 2021" and that "the Company's financial statements for this period should therefore no longer be relied upon." Based on this news, shares of Cronos fell by nearly 16%.

Keep reading... Show less
Ayurcann Holdings Corp. Reports Third Consecutive Quarter of Positive Operating Income

Ayurcann Holdings Corp. Reports Third Consecutive Quarter of Positive Operating Income

Ayurcann Holdings Corp. (CSE: AYUR, FSE: 3ZQ0) (the " Company " or " Ayurcann ") a Canadian cannabis extraction company specializing in the processing and manufacturing of cannabis to produce cannabis 2.0 and 3.0 products, is pleased to report its financial and operating results for the three-months ended September 30, 2021. All figures reported are in Canadian dollars.

HIGHLIGHTS OF FIRST QUARTER ENDED SEPTEMBER 30, 2021:

Keep reading... Show less
Greenrose Acquisition Corp. Announces Closing of Business Combination with Theraplant

Greenrose Acquisition Corp. Announces Closing of Business Combination with Theraplant

Greenrose Acquisition Corp. (OTC: GNRSU, GNRS, GNRSW) ("Greenrose" or the "Company") announced today that it has closed its previously announced business combination (the "Business Combination") with Connecticut-based Theraplant, LLC. The transaction was approved at a special meeting of Greenrose's stockholders on October 27, 2021.

The Company has been renamed The Greenrose Holding Company Inc. and will continue to be listed on the OTC under the symbols "GNRS" and "GNRSW." Greenrose also intends to co-list on the NEO exchange as soon as practicable after the close of the Business Combination.

Keep reading... Show less
Hempsana Announces Commercial Production of CBG

Hempsana Announces Commercial Production of CBG

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.

Hempsana Holdings Ltd. (the " Company " or " Hempsana "), a leading cannabis extraction company that focuses on the production of high-quality cannabis extracts, today announced its completion of it's largest commercial run of cannabigerol ("CBG").

Keep reading... Show less

Trulieve Cannabis Corp. Issues Inaugural Environmental, Social, and Governance Report

The company's first ESG report outlines efforts to operate with integrity and support
long-term sustainability

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), the largest multi-state operator (MSO) in the United States today announced the publication of its first Environmental, Social, and Governance (ESG) Report (the "Report"). The Report contains standard disclosures from the Global Reporting Initiative (GRI) Sustainability Reporting Standards, The Sustainability Accounting Standards Board (SASB) as well as the United Nations Sustainable Development Goals. The Report highlights ESG achievements to date and serves as a foundation for demonstrating how the Company's ESG approach, strategies and commitments are embedded within its core business.

Keep reading... Show less
Gage Growth Corp. Announces Record Third Quarter 2021 Results and Provides Business Update

Gage Growth Corp. Announces Record Third Quarter 2021 Results and Provides Business Update

  • Record Q3 2021 revenue of $27.2 million , an increase of 119.6% YoY and 3.2% quarter over quarter
  • Announced proposed arrangement pursuant to which TerrAscend Corp. will acquire all of the issued and outstanding subordinate voting shares of Gage
  • Closed on a $55 million senior secured term loan
  • Ended the quarter with $17.7 million of cash and $72.3 million of pro forma cash 1
  • Gross margins of 36.5% compared to 34.2% in Q2 2021, sequential quarter growth of 230 basis points
  • Q3 2021 average selling price of dried flower of approximately $4,900 /lb vs. Michigan average of approximately $3,400 /lb – 44% premium
  • The state of Michigan posted $164 million of cannabis sales in October, which equates to approximately $1.96 billion when annualized, positioning Michigan as the third largest cannabis market in the United States based on this run-rate
  • Eleven cultivation facilities in operation today (three Gage operated and eight contracted cultivation assets) compared to three cultivation facilities in Q3 2020
  • The Company introduced Gage branded vape carts in October 2021 , which currently account for almost 80% of the overall vape cart sales so far in November

Gage Growth Corp. ("Gage" or the "Company") (CSE: GAGE) (OTCQX: GAEGF), a leading high-quality cannabis premium brand and operator in Michigan today reported its record financial results for the three and nine months ended September 30, 2021 . All currency references used in this press release are in U.S. dollars unless otherwise noted.

Keep reading... Show less

Top News

Related News